CG
ZYME icon

Cutler Group’s Zymeworks ZYME Stock Holding History

Cutler Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,400
Closed -$14K – 3840
2023
Q4 		$14K Hold
1,400
– – ﹤0.01% 2210
2023
Q3 		$8K Hold
1,400
– – ﹤0.01% 2641
2023
Q2 		$12K Hold
1,400
– – ﹤0.01% 2171
2023
Q1 		$12K Sell
1,400
-1,600
-53% -$14K ﹤0.01% 2242
2022
Q4 		$23K Buy
3,000
+200
+7% +$1.41K ﹤0.01% 2129
2022
Q3 		$17K Hold
2,800
– – ﹤0.01% 2741
2022
Q2 		$14K Sell
2,800
-300
-10% -$1.81K ﹤0.01% 2980
2022
Q1 		$20K Buy
3,100
+158
+5% +$1.41K ﹤0.01% 3081
2021
Q4 		$48K Sell
2,942
-3,520
-54% -$73.4K ﹤0.01% 2431
2021
Q3 		$187K Buy
6,462
+1,900
+42% +$63.2K 0.01% 1414
2021
Q2 		$158K Hold
4,562
– – 0.01% 1517
2021
Q1 		$144K Buy
+4,562
New +$185K 0.01% 1494
2020
Q2 		– Sell
-1,900
Closed -$70K – 5009
2020
Q1 		$67K Buy
+1,900
New +$77.8K ﹤0.01% 1560
2019
Q4 		– Sell
-2,300
Closed -$83.6K – 4735
2019
Q3 		$57K Buy
2,300
+2,100
+1,050% +$52.6K 0.01% 1441
2019
Q2 		$4K Buy
+200
New +$3.67K ﹤0.01% 3284

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Cutler Group's ZYME Position: Q1 2024 in Review

Cutler Group sold out of Zymeworks (ZYME) in Q1 2024, closing a stake of 1,400 shares — an estimated $14K sold.

Cutler Group first reported a position in ZYME in Q2 2019 and held it in 15 quarters. The position peaked at $187K in Q3 2021. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Cutler Group reported no remaining Zymeworks position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 1,400 Zymeworks shares in Q1 2024, an estimated $14K.
  • Cutler Group first reported a position in Zymeworks in Q2 2019 and held it in 15 quarters.
  • Cutler Group's Zymeworks position peaked at $187K in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.